Sequential Treatment with Taxanes and Novel Anti-Androgenic Compounds in Castration-Resistant Prostate Cancer

Publisher： Karger

E-ISSN： 2296-5262|37|9|492-498

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.37, Iss.9, 2014-07, pp. : 492-498

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of castration‐resistant prostate cancer and bone metastases with radium‐223 dichloride

By  

INTERNATIONAL JOURNAL OF UROLOGICAL NURSING, Vol. 9, Iss. 1, 2015-03 ,pp. : 3-13

John Wiley & Sons Inc

Access to resources Recommend Favorite

Methylselenocysteine preventing castration‐resistant progression of prostate cancer

By  

THE PROSTATE, Vol. 75, Iss. 9, 2015-06 ,pp. : 1001-1008

John Wiley & Sons Inc

Access to resources Recommend Favorite

Role of Immunotherapy in Castration‐Resistant Prostate Cancer (CRPC)

By  

BJU INTERNATIONAL, Vol. 113, Iss. 3, 2014-03 ,pp. : 367-375

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Role of Palliative Surgery in Castration-Resistant Prostate Cancer

By  

Oncology Research and Treatment, Vol. 38, Iss. 12, 2015-0 ,pp. : 670-677

Karger

Access to resources Recommend Favorite

A phase I study of TRC105 anti‐endoglin (CD105) antibody in metastatic castration‐resistant prostate cancer

By  

BJU INTERNATIONAL, Vol. 116, Iss. 4, 2015-10 ,pp. : 546-555

John Wiley & Sons Inc

Access to resources Recommend Favorite